McKesson Corp MCK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- MX$15,346.10
- Day Range
- MX$16,580.00–16,610.00
- 52-Week Range
- MX$12,575.00–17,500.00
- Bid/Ask
- MX$16,500.00 / MX$17,660.00
- Shares Outstanding
- 116.59M
- Market Cap
- $1.94T
- Volume/Avg
- 390 / 218
Key Statistics
- Price/Earnings (Normalized)
- 22.61
- Price/Sales
- 0.28
- Dividend Yield (Trailing)
- 0.37%
- Dividend Yield (Forward)
- 0.41%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 6.16%
Company Profile
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Large Value
- Total Number of Employees
- 43,000
- Website
- https://www.mckesson.com
Competitors
Valuation
|
Metric
|
MCK
|
CAH
|
MDLN
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.61 | 21.14 | 74.98 |
Price/Book Value | — | — | 2.71 |
Price/Sales | 0.28 | 0.22 | 1.59 |
Price/Cash Flow | 18.38 | 16.06 | 18.39 |
Price/Earnings
MCK
CAH
MDLN
Financial Strength
|
Metric
|
MCK
|
CAH
|
MDLN
|
|---|---|---|---|
Quick Ratio | 0.50 | 0.43 | 2.34 |
Current Ratio | 0.89 | 0.88 | 4.33 |
Interest Coverage | 23.83 | 7.25 | 2.40 |
Quick Ratio
MCK
CAH
MDLN
Profitability
|
Metric
|
MCK
|
CAH
|
MDLN
|
|---|---|---|---|
Return on Assets (Normalized) | 5.95% | 4.62% | 2.60% |
Return on Equity (Normalized) | — | — | 14.71% |
Return on Invested Capital (Normalized) | 56.43% | 46.33% | 4.62% |
Return on Assets
MCK
CAH
MDLN
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|T%ZlMF | LOCK|^R^f | $111B | |||
| Cencora Inc
COR
| LOCK|&l!>@%y | LOCK|^PMg | $62B | |||
| Cardinal Health Inc
CAH
| LOCK|fnv!CS | LOCK|%@K> | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|#?l!G | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|lJ#SQF | LOCK|P?@# | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|L& | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|?@ | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|ZP | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|&j$< | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|$M? | $4B |
United States